Cadmium-induced osteomalacia.
Blainey JD, Adams RG, Brewer DB, Harvey TC.
Br J Ind Med. 1980 Aug;37(3):278-84. doi: 10.1136/oem.37.3.278.
Physiopathology of Phosphate Disorders.
Portales-Castillo I, Rieg T, Khalid SB, Nigwekar SU, Neyra JA.
Adv Kidney Dis Health. 2023 Mar;30(2):177-188. doi: 10.1053/j.akdh.2022.12.011.
25-Hydroxycholecalciferol absorption in steatorrhoea and postgastrectomy osteomalacia.
Gertner JM, Lilburn M, Domenech M.
Br Med J. 1977 May 21;1(6072):1310-2. doi: 10.1136/bmj.1.6072.1310.
Adverse effects of hypolipidaemic drugs.
Knodel LC, Talbert RL.
Med Toxicol. 1987 Jan-Feb;2(1):10-32. doi: 10.1007/BF03259858.
Vitamin D and bone health outcomes in older age.
Hill TR, Aspray TJ, Francis RM.
Proc Nutr Soc. 2013 Nov;72(4):372-80. doi: 10.1017/S0029665113002036. Epub 2013 Sep 11.
A Swedish cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in the treatment of iron deficiency anemia in patients with inflammatory bowel disease.
Lindgren SC, Strid H, Hjortswang H, Manxhuka B, Nanu N, Pollock RF.
J Med Econ. 2025 Dec;28(1):567-575. doi: 10.1080/13696998.2025.2487359. Epub 2025 Apr 15.
Vitamin D Deficiency in Older Patients-Problems of Sarcopenia, Drug Interactions, Management in Deficiency.
Kupisz-Urbańska M, Płudowski P, Marcinowska-Suchowierska E.
Nutrients. 2021 Apr 10;13(4):1247. doi: 10.3390/nu13041247.
Health outcomes of vitamin D. Part I. characteristics and classic role.
Wranicz J, Szostak-Węgierek D.
Rocz Panstw Zakl Hig. 2014;65(3):179-84.
Drug-induced disorders of bone metabolism. Incidence, management and avoidance.
Jones G, Sambrook PN.
Drug Saf. 1994 Jun;10(6):480-9. doi: 10.2165/00002018-199410060-00006.
Calcium gluconate supplementation is effective to balance calcium homeostasis in patients with gastrectomy.
Krause M, Keller J, Beil B, van Driel I, Zustin J, Barvencik F, Schinke T, Amling M.
Osteoporos Int. 2015 Mar;26(3):987-95. doi: 10.1007/s00198-014-2965-1. Epub 2014 Nov 13.
